(Press-News.org) Mosunetuzumab and polatuzumab combined with axicabtagene ciloleucel induce high complete response rates at day+90 in Relapsed/Refractory large B-cell lymphoma
Dr. Jay Spiegel is the presenting author and all other authors are with Sylvester or the University of Miami.
A phase 2 trial of abbreviated fixed-duration (Default 4 Cycles) linvoseltamab immuno-consolidation to deepen responses post newly diagnosed multiple myeloma combination therapy for minimal residual disease positivity (the IMMUNOPLANT Study)
Dr. Dickran Kazandjian is the presenting author and all authors are with Sylvester or the University of Miami.
A phase 2 trial of iberdomide, carfilzomib, daratumumab and dexamethasone quadruplet therapy for relapsed/refractory multiple myeloma: The rekindle study
Dr. Benjamin Diamond is the presenting author and all authors are with the Myeloma Institute at Sylvester.
Clinical translation of single cell measurable residual disease (scMRD) assay in real world Acute Myeloid Leukemia (AML) patients
Dr. Katarina Micin is the presenting author.
A Phase 2 trial of AI-BEL (AZT/Interferon-α plus Belinostat) for HTLV-1 related adult T-cell leukemia-lymphoma: Final safety and efficacy Results
Dr. Juan Carlos Ramos is the presenting author.
Preliminary data from the ongoing Phase 1 study of the menin-MLL inhibitor enzomenib (DSP-5336) in combination with venetoclax and azacitidine in patients with relapsed or refractory Acute Myeloid Leukemia
Dr. Justin Watts is the presenting author.
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes at one year following transplantation: Results from the NMDP sponsored ACCESS study
Dr. Antonio Jimenez Jimenez is the last co-author.
CAR-T efficacy in large B-cell lymphoma is shaped by neoantigen-driven epitope spreading and limited by HLA loss and genomic instability
Multiple Sylvester physicians are co-authors.
3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma
Dr. Craig Moskowitz is a co-author.
First-in-human, open-label, Phase 1 study of a novel CD30-directed antibody-drug conjugate with a topoisomerase 1 inhibitor pay- load, PF-08046044 (35C), in patients with Relapsed/Refractory lymphomas: Updated safety, PK, preliminary efficacy and ctdna analysis from dose escalation
Dr. Craig Moskowitz is a co-author.
Prognostic risk integration for survival modeling (PRISM) in newly diagnosed acute myeloid leukemia treated with venetoclax: a multinational retrospective cohort study
Drs. Ellen Madarang and Justin Watts are co-authors.
The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission
Dr. Antonio Jimenez-Jimenez is a co-author.
Safety and efficacy results from a phase 1b study of R289, a dual irak 1/4 inhibitor, in patients with Relapsed/Refractory (R/R) lower risk myelodysplastic syndrome (LR-MDS).
Dr. Mikkael Sekeres is a co-author.
Correlation between treatment-emergent cytopenias and clinical response with imetelstat (IME) in patients (Pts) with lower-risk myelodysplastic syndromes (LR-MDS): Analysis from the imerge Trial
Dr. Mikkael Sekeres is a co-author.
Ivosidenib leads to durable responses in IDH1 mutated clonal cytopenias of undetermined significance: A phase II decentralized clinical trial
Dr. Namrata Chandhok is a co-author.
Genomics define neoplastic transformation in multiple myeloma precursor conditions
Several Sylvester physicians are co-authors.
Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma
Dr. Juan Alderuccio is a co-author.
Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts
Dr. Izidore S. Lossos is a co-author.
Survival difference among patients with large B-cell lymphoma (LBCL) based on first-line clinical trial participation: A multi-institutional analysis of 8 academic institutions in the lymphoma epidemiology of outcomes (LEO) cohort
Dr. Izidore S. Lossos is a co-author.
Long-term follow-up with sustained progression-free survival (PFS) benefit after subcutaneous (SC) mosunetuzumab in combination with polatuzumab vedotin compared with rituximab plus polatuzumab vedotin in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma
Dr. Izidore S. Lossos is a co-author.
Efficacy and safety of frail adults treated with ciltacabtagene autoleucel in the real-world: A CIBMTR analysis
Dr. Lazaros Lekakis is a co-author.
Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities
Dr. Kenneth Hoehn is a co-author.
Loss of p53 enhances LMO2 induced transdifferentiation of B-cells to T-cell acute lymphoblastic leukemia
Dr. Izidore S. Lossos is presenting author and Shlomzion Aumann and Daniel Bilbao, PhD, are co-authors.
Etentamig plus pomalidomide-dexamethasone combination therapy in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study
Dr. Dickran Kazandjian is a co-author.
Novel immune gene expression signature risk-stratifies Mantle Cell Lymphoma outcomes independent of TP53 status
Drs. Jennifer Chapman and Izidore S. Lossos are co-authors.
Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database
Drs. Mikkael Sekeres and Namrata Chandhok are co-authors.
Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Final update from the Phase 1/2 BRUIN study
Dr. Alvaro Alencar is a co-author.
Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial)
Dr. Jay Spiegel is a co-author.
CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantation
Dr. Damian Green is a co-author.
Phase 1/2 dose escalation and expansion study of etentamig in patients with relapsed or refractory light chain amyloidosis
Dr. James Hoffman is a co-author.
Monotherapy update from Phase 1 portion in Phase1/2 trial of the menin-MLL inhibitor enzomenib (DSP-5336) in patients with relapsed or refractory acute leukemia
Dr. Justin Watts is a co-author.
Preliminary anti-leukemia activity from a phase 1 study of cln-049, a novel anti-FLT3 x anti-CD3 bispecific T-cell engager, in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)
Dr. Namrata Chandhok is a co-author.
Luspatercept initiated at the maximum-approved dose in transfusion-dependent lower-risk myelodysplastic syndromes: Interim analysis from maxilus
Dr. Sangeetha Venugopal is a co-author.
Bexobrutideg (NX-5948), a novel Bruton’s tyrosine kinase (BTK) degrader, demonstrates rapid and durable clinical responses in Relapsed/Refractory chronic lymphocytic leukemia (CLL): New and updated findings from an ongoing Phase 1a/b trial
Dr. Alvaro Alencar is a co-author.
Safety and efficacy of bromodomain and extra-terminal protein inhibitor INCB057643 monotherapy in patients with relapsed or refractory myelofibrosis and other advanced myeloid neoplasms: A phase 1 study
Dr. Justin Watts is a co-author.
Outcomes of T-cell/histocyte-rich large B-cell lymphoma (THRLBCL): An international LEO/MER and NiHiL collaborative study
Dr. Juan Alderuccio is the presenting author and Dr. Izidore S. Lossos is a co-author.
END
ASH 2025 tip sheet: Sylvester researchers contribute to more than 35 oral presentations at ASH Annual Meeting
2025-11-11
ELSE PRESS RELEASES FROM THIS DATE:
Feeling fit, but not fine: ECU study finds gap between athletes’ health perceptions and body satisfaction
2025-11-11
New research from Edith Cowan University (ECU) has revealed a striking disconnect between how recreational athletes perceive their health and fitness, and how they feel about their bodies.
The research found that while 69 per cent of recreational athletes that participated in a survey considered themselves healthy and 62 per cent believed they were fit, only 26 per cent reported being satisfied with their body weight and shape.
The findings confirm a concerning trend that athletes, particularly those engaged in regular or structured physical activity, are statistically more likely to experience disordered eating and exercise behaviours ...
The flexible brain: How circuit excitability and plasticity shift across the day
2025-11-11
Our brains do not react in a fixed, mechanical way like electronic circuits. Even if we see the same scene every day on our commute to work, what we feel - and whether it leaves a lasting impression - depends on our internal state at that moment. For example, your commute may be a blur if you're too tired to pay attention to your surroundings.
The 24-hour cycle that humans naturally follow is one of the factors that shapes the brain's internal environment. These internal physiological cycles arise from ...
New self-heating catalyst cleans antibiotic pollutants from water and soil
2025-11-11
Scientists have developed a fast, energy-efficient method to create an iron-carbon (Fe/C) catalyst that can remove antibiotic pollutants from both water and soil by using oxygen from the air. The study, published in Sustainable Carbon Materials, introduces a self-heating synthesis approach that could pave the way for greener environmental cleanup technologies.
Antibiotic residues such as sulfamethoxazole, commonly found in wastewater and agricultural runoff, are a growing environmental concern. These contaminants persist in the environment and ...
Could tiny airborne plastics help viruses spread? Scientists warn of a hidden infection risk
2025-11-11
As plastic pollution worsens worldwide, scientists are uncovering a new and unsettling possibility. Tiny airborne fragments of plastic, known as micro- and nanoplastics, may do more than pollute the air we breathe. They could also help viruses linger and travel farther, potentially influencing how respiratory diseases spread.
A commentary published in New Contaminants by Mengjie Wu and Huan Zhong of Nanjing University calls attention to the emerging concern that airborne plastics might act as invisible vehicles for viruses. While plastics ...
Breakthrough in water-based light generation: 1,000-fold enhancement of white-light output using non-harmonic two-color femtosecond lasers
2025-11-11
Scientists at Japan's Institute for Molecular Science have achieved a 1,000-fold enhancement in white-light generation inside water by using non-harmonic two-color femtosecond laser excitation. This previously unexplored approach in liquids unlocks new nonlinear optical pathways, enabling a dramatic boost in supercontinuum generation. The breakthrough lays a foundation for next-generation bioimaging, aqueous-phase spectroscopy, and attosecond science in water.
Researchers at the Institute for Molecular ...
Food stamp expansion in 2021 reduced odds of needy US kids going hungry
2025-11-11
The 15% expansion of food stamp payments under the supplemental nutrition assistance program, or SNAP for short, during the COVID-19 pandemic, reduced the odds of needy children going hungry, especially in Hispanic-American and large households, finds research to be published online in the Journal of Epidemiology & Community Health.
The findings are particularly relevant, given the projected 9-10% benefit reductions ($15/household/month) for typical families by 2034 under the terms of the 2025 Reconciliation Bill enacted in July ...
Cash transfers boost health in low- and middle-income countries
2025-11-11
Philadelphia, PA — Large-scale, government-led cash transfer programs drove significant improvements in health outcomes across low- and middle-income countries (LMICs), according to a major new study in The Lancet from researchers at the University of Pennsylvania Perelman School of Medicine. More women received health care early in their pregnancies, more babies were born in health facilities, and more births were attended by trained health workers when governments gave money through cash transfer programs.
Giving cash leads to massive health improvements
Researchers ...
LDL cholesterol improved among veterans in program with health coaches, other resources
2025-11-10
Research Highlights:
After 24 months, 34% of veterans who have heart and blood vessel disease and high cholesterol in a quality improvement program that included health care coaches and other resources had improved cholesterol levels to below 70 mg/dL.
The quality-improvement program increased the number of military veterans with better LDL (“bad” cholesterol) levels of less than 70mg/dL, and more than a third of those ages 75 and older achieved their lower cholesterol goal.
Note: The study featured in this news release is a research abstract. Abstracts ...
New study finds novel link between shared brain-gene patterns and autism symptom severity in children with autism and ADHD
2025-11-10
NEW YORK, NY (November 2025) A new study published in Molecular Psychiatry reveals that the biological underpinnings of autism and ADHD may transcend traditional diagnostic boundaries. While there is increasing appreciation that ADHD and autism often co-occur, the underlying shared biological features have remained largely unknown. Researchers from the Child Mind Institute and collaborating institutions discovered that autism symptom severity, rather than diagnostic classification, corresponds to distinct ...
For Black adults in food deserts, food delivery & dietary guidance reduced blood pressure
2025-11-10
Research Highlights:
A grocery support program based on the low-sodium DASH eating plan that included home-delivered groceries and dietary counseling reduced blood pressure levels in Black adults living in areas where grocery stores were inaccessible or scarce, known as food deserts.
People who had groceries delivered to their homes and followed guidance from a dietitian for three months had greater improvements in blood pressure and cholesterol levels, compared to a similar group in the same community ...